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T
he immune system protects the body by relying 
on specialized cells that can recognize billions of 
pathogenic foreign particles. This recognition is 
achieved through the generation of a highly diverse collection 
of antigen receptors, expressed at the surface of B and T 
lymphocytes, that are made by random recombination of V, 
(D), and J segments and trimming/addition of nucleotides 
at the junctions between these rearranged gene segments. 
Such mechanisms ensure the creation of a vast repertoire of 
receptors that is necessary to survey the multitude of antigens 
that continuously challenge the immune system. In contrast 
to the enormous receptor diversity of antigen receptors 
found on conventional B and T cells, several lymphocyte 
subpopulations with limited repertoire diversity have been 
identified. This includes the B1 B cell subset [1], some γδ T 
cell subpopulations [2], the natural killer T (NKT) cells [3], 
and the mucosal-associated invariant T (MAIT) cells [4]. 
These discrete subpopulations tend to be phylogenetically 
conserved, localize to specific tissues, and are often 
considered to act at the frontier between innate and adaptive 
immunity: like adaptive immune cells, they generate antigen 
receptors through V(D)J recombination, but like innate 
immune cells, they tend to recognize a limited set of antigens 
and respond quickly to an immune challenge.
Invariant NKT Cells
The majority of NKT cells express a T cell receptor (TCR) 
that is the product of a canonical Vα14-Jα18 (Vα24 in 
humans) rearrangement, with the junctional region invariant 
at the amino acid level. This Vα14 invariant chain is co-
expressed with a limited set of Vβ chains, which together 
form a functional αβ receptor. In mice and humans, this NKT 
cell population is referred to as type I NKT cells, or invariant 
(iNKT) cells [5]. While the majority of “conventional” 
αβ TCR+ cells respond to peptides bound to conventional 
major histocompatibility complex class I (MHCI) and class II 
(MHCII) molecules, iNKT cells recognize glycolipid antigens 
presented by the MHCIb molecule, CD1d [6]. A hallmark 
feature of MHCI and MHCII proteins is the extensive 
polymorphism in residues that constitute their peptide-
binding groove, which forms the basis for differential peptide 
binding, thymic repertoire formation, and allograft rejection. 
In contrast, CD1d molecules are essentially nonpolymorphic 
among inbred strains of mice and humans, suggesting that 
these molecules likely evolved to present only a limited set of 
glycolipidic antigens. The high degree of conservation of the 
canonical TCR and CD1d molecules allows for interspecies 
cross-reactivity, with mouse iNKT cells recognizing human 
CD1d and vice versa, indicating the likely importance of these 
cells in the immune system. 
MAIT Cells
Like iNKT cells, MAIT cells are also characterized by the 
expression of a semi-invariant TCR rearrangement (Vα7.2-
Jα33 in humans and Vα19-Jα33 in mice), with a junction of 
constant length but some variability in two junctional codons 
[7,8]. This invariant α chain is also found preferentially 
associated with a limited number of TCRβ chains (Vβ2 and 
Vβ13 chains in humans and Vβ6 and Vβ8 chains in mice). 
Such TCRs recognize another MHCIb molecule highly 
conserved in mammals, MHC-related molecule 1 or MR1 
[9]. Compelling evidence that MR1 molecules likely present 
antigens to MAIT cells has been published [10]; however, 
the nature of these antigens remains currently unknown. 
This expression of a highly conserved invariant Vα chain 
coupled to the recognition of a non-polymorphic MHCI-like 
molecule, their preferential homing to specific tissues, and 
their currently defined phenotype (see below) has won this 
population the acronym of mucosal NKT or mNKT cells [11]. 
Developing new reagents has helped us define invariant 
T cell populations. For example, the generation of CD1d 
tetramers loaded with the prototypical glycolipid antigen, 
α-galactosylceramide, permitted the specific detection of 
iNKT cells in both mice and humans [12]. Using this reagent, 
important progress in our understanding of the ontogeny, 
developmental requirements, phenotype, tissue localization, 
and function(s) of iNKT cells has been achieved [13,14]. 
Unfortunately, until recently the only way to detect MAIT cells 
in humans and unmanipulated mice was through molecular 
techniques targeting the invariant TCRα chain [9], which 
prevented the in-depth exploration of MAIT cell biology.
In this issue of PLoS Biology, Emmanuel Martin and 
colleagues at the Lantz laboratory now report the isolation 
of a monoclonal antibody directed against the human 
Vα7.2 chain that is part of the MAIT TCR [15]. Just as 
the generation of the CD1d tetramer revolutionized how 
investigators could study iNKT cells, one might predict that 
the development of this monoclonal antibody will profoundly 
impact the MAIT cell field. Using this new reagent, as well 
as several genetically modified mice, the Lantz laboratory 
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has focused their first study on the development of MAIT 
cells. The status quo of our understanding of MAIT cell 
development is depicted in Figure 1 and compared to iNKT
cell development.
Using molecular techniques to measure the amount of 
invariant TCRα chain in peripheral organs, it was previously 
established that MAIT cell development is dependent upon 
the expression of MR1 on bone marrow-derived cells. It 
was also shown that MAIT cells accumulate in the epithelial 
layer of the intestinal lining in a process dependent on 
commensal flora and on the presence of B cells, suggesting 
the possibility that MAIT might in fact be directed against 
some microbial antigens presented by MR1 molecules at 
the surface of B cells [9]. However, it is known that some 
intraepithelial T lymphocytes might be generated by extra-
thymic lymphopoiesis, and given that MAIT cells could 
not be detected in the thymus of either humans or wild-
type mice, their origin and developmental requirements 
remained elusive. In this new study, the authors were able 
to detect MAIT cells in the human thymus and in mouse 
fetal thymic organ cultures. Together with the observation 
that MAIT cells are absent in athymic nu/nu (nude) mice 
[8], these results make a compelling case that MAIT cells, 
like iNKT cells, likely develop in the thymus. In agreement 
with previous findings, MAIT cells were essentially found 
within the CD4−CD8−double negative (DN) and CD8αβ+
populations, with very few CD4+ cells expressing the 
canonical TCR. In addition, some cells appear to express the 
homodimer CD8αα in humans. Interestingly, human cord 
blood MAIT cells, as well as mouse MAIT cells, displayed 
a naïve phenotype (i.e., lacked expression of receptors 
associated with prior antigen exposure) with no significant 
expression of several markers (including NK1.1, CD25, CD69, 
and ICOS) that had been previously used to identify MAIT 
cells in other TCR transgenic mice [16,17]. The reasons 
for such a discrepancy remain unclear at the moment but 
might be related to differences in experimental procedures 
and/or mouse colony housing. By contrast, in human adult 
blood, MAIT cells, like iNKT cells, have a memory phenotype 
(i.e., expressed several markers usually found on antigen-
experienced T cells) and expressed the NK marker CD161 
(NKRP1A), which, importantly, is not the human ortholog of 
the mouse NK1.1 marker (NKR-P1B/C in B6 mice) [18]. 
What do all these results mean? The simplest and 
most logical explanation is that MAIT cells originate and 
undergo positive selection in the thymus and are exported 
to peripheral organs while retaining their naïve phenotype. 
Because B cells are absent from fetal thymic organ cultures, 
the results also suggest that B cells are not required for the 
development of MAIT cells per se but might be needed 
for the expansion and/or final maturation of MAIT cells 
in the periphery. In support of this hypothesis, Martin 
et al. performed experiments adding back B cells, either 
expressing or lacking the MR1 molecule, to transgenic mice 
engineered to express only the MAIT TCR at the surface of 
all T cells. Originally, very few MAIT cells were detected in 
the peripheral organs of these animals, but their number 
increased over 10-fold during a two-week period after B cells 
were transferred into the mice. Interestingly, MR1-deficient 
B cells were almost as efficient at inducing this expansion 
as MR1-expressing cells, suggesting that cognate interaction 
between the invariant TCR and MR1 might not be necessary 
for this expansion. Such results might perhaps have been 
expected in light of the extremely low to undetectable levels 
of MR1 expression at the surface of ex vivo purified cells [19]. 
Indeed, although MR1 mRNA expression seems ubiquitous 
[20,21], endogenous cell surface expression of MR1 in vivo 
remains unclear. Further work will be necessary to decipher 
the exact role of B cells in MAIT cell expansion and to 
determine which MR1-expressing cell type is responsible for 
the positive selection of MAIT cells in the thymus. 
MAIT Cells Are Not iNKT Cells
iNKT cells also develop in the thymus and are positively 
selected by bone marrow-derived double positive (DP) 
thymocytes that express CD1d. Following positive selection 
at the DP stage, iNKT cells also undergo an orchestrated 
maturation process that ultimately leads to the acquisition 
of their activated NK-like phenotype. However, when iNKT
cells leave the thymus they are still in an immature stage (as 
defined by the absence of expression of NK receptors such as 
NK1.1) and fulfill their terminal maturation in the periphery 
[14]. As for MAIT cells, it is currently unclear what signal(s) 
regulate iNKT cell terminal maturation. The adaptor SLAM-
associated protein (SAP) and the transcription factor Zbtb16 
(PLZF) were both recently reported to be essential to the 
proper development of iNKT cells [22–24]. Martin et al. 
examined whether these two molecules also influence the 
development of MAIT cells. While no iNKT cells could be 
detected in the blood of five SAP-deficient patients, MAIT 
cells were present with a normal frequency and phenotype. 
These results suggest that, in contrast to iNKT cells, the 
cooperative engagement of homophilic receptors of the 
signaling lymphocytic-activation molecule (SLAM) family, 
whose signaling properties are mediated through SAP, is not 
involved in the development of MAIT cells. The results for 
Zbtb16 turned out to be more complicated. Zbtb16 is not 
expressed in mouse MAIT cells, which, in this study, have a 
naïve phenotype, but is found at high levels in human blood 
MAIT cells that express an activated/memory phenotype. 
The correlation between the “memory” phenotype of MAIT 
cells and the expression of Zbtb16 clearly associates this 
transcription factor with the acquisition of this particular 
phenotype. In fact, recent work showed that forced 
expression of Zbtb16 in T cells, using transgenesis, induced 
T cells with an antigen-experienced phenotype that could 
quickly produce the cytokine interferon-γ upon stimulation, a 
characteristic of innate-like immune cells [25]. The questions 
remain as to what signals induce Zbtb16 expression in 
iNKT cells and human MAIT cells and what species-specific 
differences between mice and humans are responsible for this 
differential MAIT cell phenotype.
MAIT Cells Continue To Intrigue Us
While certain similarities indeed exist between the two iNKT
and MAIT cell populations, the current study clearly outlines 
major differences in their developmental requirements and 
phenotype. Furthermore, these new findings prompt us 
to re-evaluate many important questions regarding MAIT 
cells. First, what are the effector functions of MAIT cells? In 
agreement with their previously defined effector/memory 
phenotype and similarly to iNKT cells, MAIT cells had 
previously been shown to rapidly produce effector cytokines 
(including interleukin-4, interleukin-5, interleukin-10, PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 0437 March 2009  |  Volume 7  |  Issue 3  |  e1000070
tumor necrosis factor-α, and interferon-γ  after activation 
via MR1 [16,17]. However, Martin et al. now challenge 
previous reports indicating that MAIT cells have an activated 
phenotype in mice. This inconsistency makes it particularly 
important to determine whether MAIT cells derived from 
the current transgenic mice and human Vα7.2+ CD161+ cells 
doi:10.1371/journal.pbio.1000070.g001
Figure 1. Schematic View of iNKT Cell and MAIT Cell Development
NKT and MAIT cells both arise in the thymus from uncommitted DN precursors. The cells progress to the DP CD4+ CD8+ stage, where they presumably 
randomly rearrange the TCR. Thymocytes that express a TCR that interacts with CD1d bound to self-glycolipid, expressed by other DP thymocytes, 
enter the iNKT lineage. Homotypic interactions between SLAM and Ly108 molecules, also expressed at the surface of DP thymocytes, are required for 
progression into the iNKT cell lineage. Thymocytes that express a TCR that interacts with MR1 expressed at the surface of an undefined myeloid cell 
type are positively selected into the MAIT cell lineage. Such lineage commitment does not require SLAM/SAP signaling. Whether other specific signaling 
pathways are required for the generation of MAIT cells remains to be determined. After selection, iNKT cell precursors undergo a series of differentiation 
steps characterized by the sequential expression of several cell surface markers (HSA [heat-stable antigen], CD44, and NK1.1), as depicted. How MAIT 
cells mature to their characteristic phenotype is currently unknown. The earliest iNKT cell precursor found in the thymus expresses the highest level 
of the transcription factor Zbtb16. Zbtb16 expression level then decreases as the cell progresses further in the differentiation pathway. At least four 
distinct immature iNKT cell populations have been identified in the thymus. Most iNKT cells that emigrate from the thymus do so in an immature form 
(CD44high, NK1.1−) and can continue their final maturation in the periphery (spleen/liver). Some mature iNKT cells also migrate to the periphery, but 
many remain as long-term residents of the thymus. MAIT cells leave the thymus with a naïve phenotype and expand in peripheral organs such as the 
lymph nodes and the mucosa epithelia (such as the lamina propria), where they expand upon interactions with B cells. This cell expansion is associated 
with the expression of Zbtb16 and the acquisition of a “memory” phenotype.PLoS Biology  |  www.plosbiology.org PLoS Biology  |  www.plosbiology.org 0438 March 2009  |  Volume 7  |  Issue 3  |  e1000070
indeed behave like innate lymphocytes by producing rapidly 
effector cytokines upon stimulation, or not.
Second, where are MAIT cells located? MAIT cells derive 
their name from the findings that the invariant TCRα chain is 
enriched (in humans and mice) in lymphocyte preparations 
derived from the gut (the lining lamina propria and Peyer’s 
patches) and perhaps the lungs [9]. The current study did not 
assess whether MAIT cells might be located in other tissues, 
but the newly made anti-Vα7.2 monoclonal antibody will 
certainly facilitate this task in the future. Strikingly, Martin et 
al. showed that MAIT cells represent up to 1%–4% of total 
blood T cells, which greatly exceeds the reported frequency of 
iNKT cells (generally less than 0.2% of total peripheral blood 
lymphocytes [26]). The high frequency of MAIT cells could 
potentially correlate with important functions in humans. The 
next challenge will be to determine what these functions might 
be and whether the frequency and number of MAIT cells 
varies under different conditions, such as during infections 
or in the presence of tumors or autoimmunity. Due to their 
prominence in the intestine, it was previously suggested 
that MAIT cells might have a positive role in regulating the 
secretion of immunoglobulin A molecules that are resistant to 
enzyme degradation in the harsh environment of the digestive 
tract [9,27]. This possibility awaits experimental confirmation. 
Other reports have also suggested the accumulation of MAIT 
cells in central nervous system lesions from multiple sclerosis 
autopsy samples [28] and in human kidney and brain tumors 
[29]. MAIT cells have also been proposed to have a protective 
role during experimental autoimmune encephalomyelitis, a 
mouse model of multiple sclerosis [17]. 
Finally, the nature of the antigen(s) recognized by MAIT 
cells in vivo remains unknown. Evidence suggests that it might 
not be of peptidic nature, and MAIT cells have been shown 
to be stimulated by the glycolipid α-mannosylceramide [30]. 
The significance of these findings remains unclear, as they 
have been difficult to reproduce [31], and the putative ligand-
binding groove of MR1 does not appear especially suited for 
lipid binding. Nevertheless, the conserved nature of the MAIT 
cell TCR and its restriction element MR1 suggests the potential 
recognition of a conserved class of antigenic ligand(s). How 
this invariant TCR might recognize the antigen/MR1 complex 
remains unknown. Mutational analysis of MR1 molecules has 
predicted a traditional diagonal binding of the TCR on MR1 
[19]. Similar predictions were made regarding the engagement 
of the iNKT TCR onto CD1d. Yet, the recent crystal structure 
of a human iNKT TCR in complex with α-galactosylceramide 
presented by CD1d demonstrated a striking engagement of the 
TCR [32]. It was proposed that the iNKT TCR behaves as a 
pattern recognition receptor and is less “ligand-discriminating” 
than other TCRs reactive with MHCIa and MHCII molecules 
[33]. Whether MAIT TCR functions in a similar manner 
remains to be determined. Such a possibility, given the 
prominence of these cells in humans, might reveal MAIT cells 
as a major player in mucosal immune regulation.  
References
1. Hardy RR, Hayakawa K (2001) B cell development pathways. Annu Rev 
Immunol 19: 595-621.
2. Haas W, Pereira P, Tonegawa S (1993) γδ cells. Annu Rev Immunol 11: 637-
685.
3. Bendelac A, Savage PB, Teyton L (2007) The biology of NKT cells. Annu 
Rev Immunol 25: 297-336.
4. Treiner E, Duban L, Moura IC, Hansen T, Gilfillan S, et al. (2005) Mucosal-
associated invariant T (MAIT) cells: An evolutionarily conserved T cell 
subset. Microbes Infect 7: 552-559.
5. Godfrey DI, MacDonald HR, Kronenberg M, Smyth MJ, Van Kaer L (2004) 
NKT cells: What’s in a name? Nat Rev Immunol 4: 231-237.
6. Bendelac A, Lantz O, Quimby ME, Yewdell JW, Bennink JR, et al. (1995) 
CD1 recognition by mouse NK1+ T lymphocytes. Science 268: 863-865.
7. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell 
antigen receptor (TCR) expression by human peripheral blood CD4-8- αβ 
T cells demonstrates preferential use of several Vβ genes and an invariant 
TCR α chain. J Exp Med 178: 1-16.
8. Tilloy F, Treiner E, Park SH, Garcia C, Lemonnier F, et al. (1999) An 
invariant T cell receptor α chain defines a novel TAP- independent major 
histocompatibility complex class Ib-restricted αβ T cell subpopulation in 
mammals. J Exp Med 189: 1907-1921.
9. Treiner E, Duban L, Bahram S, Radosavljevic M, Wanner V, et al. (2003) 
Selection of evolutionarily conserved mucosal-associated invariant T cells by 
MR1. Nature 422: 164-169.
10. Hansen TH, Huang S, Arnold PL, Fremont DH (2007) Patterns of 
nonclassical MHC antigen presentation. Nat Immunol 8: 563-568.
11. Wingender G, Kronenberg M (2008) Role of NKT cells in the digestive 
system. IV. The role of canonical natural killer T cells in mucosal immunity 
and inflammation. Am J Physiol Gastrointest Liver Physiol 294: G1-G8.
12. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, et al. 
(2000) Tracking the response of natural killer T cells to a glycolipid antigen 
using CD1d tetramers. J Exp Med 192: 741-754.
13. Matsuda JL, Gapin L (2005) Developmental program of mouse Vα14i NKT 
cells. Curr Opin Immunol 17: 122-130.
14. Matsuda JL, Mallevaey T, Scott-Browne J, Gapin L (2008) CD1d-restricted 
iNKT cells, the ‘Swiss-Army knife’ of the immune system. Curr Opin 
Immunol.
15. Martin E, Treiner E, Duban L, Guerri L, Laude H, et al. (2009) Stepwise 
development of MAIT cells in mouse and human. PLoS Biol 7(3): 
e1000054. doi:10.1371/journal.pbio.1000054
16. Kawachi I, Maldonado J, Strader C, Gilfillan S (2006) MR1-restricted Vα19i 
mucosal-associated invariant T cells are innate T cells in the gut lamina 
propria that provide a rapid and diverse cytokine response. J Immunol 176: 
1618-1627.
17. Croxford JL, Miyake S, Huang YY, Shimamura M, Yamamura T (2006) 
Invariant Vα19i T cells regulate autoimmune inflammation. Nat Immunol 
7: 987-994.
18. Mesci A, Ljutic B, Makrigiannis AP, Carlyle JR (2006) NKR-P1 biology: 
From prototype to missing self. Immunol Res 35: 13-26.
19. Huang S, Gilfillan S, Cella M, Miley MJ, Lantz O, et al. (2005) Evidence for 
MR1 antigen presentation to mucosal-associated invariant T cells. J Biol 
Chem 280: 21183-21193.
20. Riegert P, Wanner V, Bahram S (1998) Genomics, isoforms, expression, and 
phylogeny of the MHC class I-related MR1 gene. J Immunol 161: 4066-4077.
21. Hashimoto K, Hirai M, Kurosawa Y (1995) A gene outside the human MHC 
related to classical HLA class I genes. Science 269: 693-695.
22. Griewank K, Borowski C, Rietdijk S, Wang N, Julien A, et al. (2007) 
Homotypic interactions mediated by Slamf1 and Slamf6 receptors control 
NKT cell lineage development. Immunity 27: 751-762.
23. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, et al. (2008) The BTB-
zinc finger transcriptional regulator, PLZF, controls the development of 
iNKT cell effector functions. Nat Immunol 9: 1055-1064.
24. Savage AK, Constantinides MG, Han J, Picard D, Martin E, et al. (2008) 
The transcription factor PLZF directs the effector program of the NKT cell 
lineage. Immunity 29: 391-403.
25. Raberger J, Schebesta A, Sakaguchi S, Boucheron N, Blomberg KE, et al. 
(2008) The transcriptional regulator PLZF induces the development of 
CD44 high memory phenotype T cells. Proc Natl Acad Sci U S A 105: 17919-
17924.
26. Lee PT, Putnam A, Benlagha K, Teyton L, Gottlieb PA, et al. (2002) Testing 
the NKT cell hypothesis of human IDDM pathogenesis. J Clin Invest 110: 
793-800.
27. Treiner E, Lantz O (2006) CD1d- and MR1-restricted invariant T cells: Of 
mice and men. Curr Opin Immunol 18: 519-526.
28. Illes Z, Shimamura M, Newcombe J, Oka N, Yamamura T (2004) 
Accumulation of Vα7.2-Jα33 invariant T cells in human autoimmune 
inflammatory lesions in the nervous system. Int Immunol 16: 223-230.
29. Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, et al. (2008) Invariant 
Vα7.2-Jα33 TCR is expressed in human kidney and brain tumors indicating 
infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 20: 
1517-1525.
30. Shimamura M, Huang YY, Okamoto N, Suzuki N, Yasuoka J, et al. (2007) 
Modulation of Vα19 NKT cell immune responses by α-mannosyl ceramide 
derivatives consisting of a series of modified sphingosines. Eur J Immunol 
37: 1836-1844.
31. Huang S, Gilfillan S, Kim S, Thompson B, Wang X, et al. (2008) MR1 uses 
an endocytic pathway to activate mucosal-associated invariant T cells. J Exp 
Med 205: 1201-1211.
32. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, et al. (2007) 
CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. 
Nature 448: 44-49.
33. Scott Browne J, Matsuda JL, Mallevaey T, Borg NA, White J, et al. (2007) 
Germline-encoded recognition of diverse glycolipids by NKT cells. Nat 
Immunol 8: 1105-1113.